{"title":"Solid Dispersion Method for Design of Donepezil Orodispersible Tablets: Formulation & Characterization","authors":"Naga Sai D, K. V, C. Sb, B. B","doi":"10.46624/ajptr.2019.v9.i3.015","DOIUrl":null,"url":null,"abstract":"Please cite this article as: Bhavani B et al., Solid Dispersion Method for Design of Donepezil Orodispersible Tablets: Formulation & Characterization. American Journal of PharmTech Research 2019. Solid Dispersion Method for Design of Donepezil Orodispersible Tablets: Formulation & Characterization Naga Sai D, Krishna Veni V, Chandra Sekhar SB, Bhavani B* 1.Koringa College of Pharmacy, Tallarevu, East Godavari 2.Drug Testing Laboratory, Karnataka ABSTRACT Donepezil HCl is an anti Alzheimer’s drug of the acetylcholinesterase class. It is widely used in treatment of Alzheimer’s disease and to control dementia. Orodispersable Tablets (ODTs) containing Donepezil HCl was prepared using super-disintegrant (croscarmellose sodium) by direct compression method using solid dispersion technique to mask the taste of the drug. Three types of excipient were used to mask the taste namely Mannitol, PEG 6000 and PVP K 30 in three different ratios (i.e. 1:1, 1:2, 1:3) using solvent evaporation method in solid dispersion technique. The optimized formulation shows the minimum disintegration time of 50 sec and release maximum amount of drug in 10 min. Short term stability studies indicated no significant changes in hardness, friability, in vitro disintegration time, drug content and in vitro drug release.","PeriodicalId":7701,"journal":{"name":"American Journal of PharmTech Research","volume":"12 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of PharmTech Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46624/ajptr.2019.v9.i3.015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Please cite this article as: Bhavani B et al., Solid Dispersion Method for Design of Donepezil Orodispersible Tablets: Formulation & Characterization. American Journal of PharmTech Research 2019. Solid Dispersion Method for Design of Donepezil Orodispersible Tablets: Formulation & Characterization Naga Sai D, Krishna Veni V, Chandra Sekhar SB, Bhavani B* 1.Koringa College of Pharmacy, Tallarevu, East Godavari 2.Drug Testing Laboratory, Karnataka ABSTRACT Donepezil HCl is an anti Alzheimer’s drug of the acetylcholinesterase class. It is widely used in treatment of Alzheimer’s disease and to control dementia. Orodispersable Tablets (ODTs) containing Donepezil HCl was prepared using super-disintegrant (croscarmellose sodium) by direct compression method using solid dispersion technique to mask the taste of the drug. Three types of excipient were used to mask the taste namely Mannitol, PEG 6000 and PVP K 30 in three different ratios (i.e. 1:1, 1:2, 1:3) using solvent evaporation method in solid dispersion technique. The optimized formulation shows the minimum disintegration time of 50 sec and release maximum amount of drug in 10 min. Short term stability studies indicated no significant changes in hardness, friability, in vitro disintegration time, drug content and in vitro drug release.
请引用这篇文章:Bhavani B et al.,固体分散法设计多奈哌齐口服分散片:配方与表征。美国医药技术研究杂志2019。多奈哌齐口腔分散片的固体分散法设计:处方与表征科林加药学院,塔拉雷乌,东戈达瓦里盐酸多奈哌齐是一种抗阿尔茨海默病的乙酰胆碱酯酶类药物。它被广泛用于治疗阿尔茨海默病和控制痴呆症。采用固体分散技术,采用超崩解剂(交联棉糖钠)直接压缩法制备盐酸多奈哌齐口腔分散片。采用固体分散技术中的溶剂蒸发法,以甘露醇、PEG 6000和PVP K 30三种不同的配比(1:1、1:2、1:3)掩盖味。优化后的处方最短崩解时间为50秒,最大释药量为10 min。短期稳定性研究表明,其硬度、脆度、体外崩解时间、药物含量和体外释药量均无明显变化。